Preston, Australia

Rashmi Pathak

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Starpharma Pty Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rashmi Pathak. Retrieved from https://idiyas.com/inventor/rashmi-pathak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rashmi Pathak and Therapeutic Dendrimer Innovation

Introduction

Rashmi Pathak is an inventor associated with Preston, Australia, and Starpharma Pty Limited. Her listed patent work concerns a therapeutic dendrimer designed for potential pharmaceutical and medical applications.

Latest Patents

Pathak is associated with 1 patent, titled “Therapeutic dendrimer.” The invention describes dendrimers with a core unit and five generations of building units made from lysine residues or their analogues. Their terminal groups include nucleoside analogue residues and hydrophilic polymeric groups. The patent also describes pharmaceutical compositions containing these dendrimers and their potential use in treating disorders such as cancer.

Career Highlights

The available information identifies Pathak’s work with Starpharma Pty Limited and her contribution to research involving dendrimer-based therapeutic approaches. The described invention combines a structured molecular framework with components intended for pharmaceutical use.

Collaborations

Pathak’s listed coworker is David James Owen. Their association is connected to the therapeutic dendrimer patent and its potential applications in medicine.

Conclusion

Rashmi Pathak’s patent work reflects an effort to develop dendrimer-based pharmaceutical technologies, including approaches with potential relevance to cancer therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…